Clinical trials are medical research studies in which people participate as volunteers. They help researchers learn more about diseases and conditions and develop new treatments and medications. Learn more about clinical trials aquí.
A continuación se enumeran los ensayos clínicos que actualmente están reclutando pacientes con miositis juvenil. Los pacientes con MJD y MJP de distintas edades pueden participar en estos ensayos. Para obtener información detallada sobre un ensayo en particular, póngase en contacto directamente con el equipo del estudio.
Si tiene alguna pregunta, póngase en contacto con la Directora de Educación Familiar y Clínica de Cure JM, Ashley Renfrow, RN, NP-C, en la dirección ashley.renfrow@curejm.org.
Ensayo CAR-T de Cabaletta Bio
RESET-Miositis: Estudio abierto para evaluar la seguridad y eficacia de CABA-201 en sujetos con miopatía inflamatoria idiopática activa.
Cabaletta Bio RESET-Myositis Trial:
RESET-Myositis is a phase 1/2 clinical trial being conducted to evaluate the effects of an investigational CAR-T treatment, called CABA-201, in myositis.
Who is eligible for this clinical trial?
You or someone you know may be eligible to participate if you:
- Have been diagnosed with myositis or juvenile myositis, including juvenile dermatomyositis and juvenile polymyositis patients
- Are 18+ years of age
- Tienen la enfermedad activa
- Additional requirements will apply, and only a study doctor can determine eligibility to participate in the study.
- Recruitment is currently open at the following locations below. For a full list of study sites click here.
- Condado de Orange, CA
- Jacksonville, FL – Mayo Clinic
- Chicago, IL – Northwestern Memorial Hospital
- Chicago, IL – University of Chicago Medical Center
- Kansas City, KS – University of Kansas Medical Center
- Rochester, MN – Mayo Clinic
- Portland, OR – Oregon Health & Science University
- Nashville, TN – Vanderbilt University Medical Center
- Houston, TX – Houston Methodist Hospital
- Houston, TX – University of Texas MD Anderson Medical Center
Next Steps If You Are Interested:
- Speak with Your Doctor: Discuss this trial with your healthcare provider to determine if it’s a good fit.
- Contact the Study Team: Reach out to the research team for detailed information, including eligibility requirements, locations, and potential risks and benefits. Please email clinicaltrials@cabalettabio.com and the study site closest to you. Find the list of study sites aquí.
- Ask Questions: It’s important to fully understand the trial’s process, expectations, and how participation might affect your care.
Cabaletta Bio RESET-Myositis Trial FAQs can be reviewed aquí.
Teléfono: +1-267-759-3100
MÁS INFORMACIÓN SOBRE ESTE ENSAYO
Correo electrónico: clinicaltrials@cabalettabio.com
Ensayo CAR-NK de Century Therapeutics
Los pacientes de JDM y JPM mayores de 17 años pueden participar; póngase en contacto con uno de los centros mencionados aquí. This study is called the CALiPSO-1 Study. It is a study of CNTY-101, which is a CD19-targeted CAR-NK Cell Product. This is being tested in participants with refractory B Cell-mediated autoimmune diseases like JDM and JPM.
Note: You may see the term “IIM” listed on the trial site. In medicine, IIM stands for Idiopathic Inflammatory Myopathies. IIM refers to the group of rare diseases is characterized by chronic muscle inflammation and includes conditions like JDM, JPM, and others.
Si tiene alguna pregunta, póngase en contacto con la Directora de Educación Familiar y Clínica de Cure JM, Ashley Renfrow, RN, NP-C, en la dirección ashley.renfrow@curejm.org.
